Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105

Benzinga Newsdesk www.benzinga.com Positive 78.6%

Neg 0% Neu 0% Pos 78.6%

Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $92 to $105.